Plasma Therapy Treatment | COVID-19 | How its Works | Corona Virus Treatment - Bundles Of Knowledge
Bundles Of Knowledge
2020-04-11
Views 6
Plasma Therapy Treatment | COVID-19 | How its Works | Corona Virus Treatment - Bundles Of Knowledge
#Plasmatherapy #covid19 #plasmatreatment #plasmatreatmenturdu
What is convalescent plasma therapy?
A newly approved treatment with some history of success could offer hope for the sickest of the country’s COVID-19 patients.
The U.S. Food and Drug Administration has approved the use of convalescent plasma therapy as an experimental treatment in clinical trials and for critically ill COVID-19 patients without other treatment options.
The therapy, which takes antibodies from the blood of a person who has recovered from a virus and transfuses those antibodies into a person sick with that virus, has long been used as a way to help kickstart a person’s immune system.
Since the March 24 FDA approval, 11 critically ill COVID-19 patients in New York City and Houston received experimental treatment using convalescent care. The results of those cases have not been reported yet.
The therapy has also been used in other parts of the world.
A study of 10 patients in China who have undergone convalescent therapy showed a shortening of the duration of symptoms, improve oxygen levels and a drop in the “virus load” or the amount of virus in a person’s body.
With a vaccine likely months to a year away, scientists hope that convalescent plasma therapy can help those sickest with the virus now.
How does the therapy work, who can it help and what are the results so far? Here’s what we know about convalescent plasma therapy.
What is convalescent plasma?
Convalescent plasma therapy involves transfusing certain components from the blood of people who have had the COVID-19 virus and recovered into people who are very sick with the virus or people who are at high risk of getting the virus.
How does it work
As people fight the COVID-19 virus, they produce antibodies that attack the virus. Those antibodies, proteins that are secreted by immune cells known as B lymphocytes, are found in plasma, or the liquid part of blood that helps the blood to clot when needed and supports immunity.
Once a person has had the virus and recovered, that person has developed antibodies that will stay in their blood waiting to fight the same virus should it return. Those antibodies, when injected into another person with the disease, recognize the virus as something to attack.
In the case of the coronavirus, scientists say antibodies attack the spikes on the outside of the virus, blocking the virus from penetrating human cells.
Who would it help?
Researchers hope that convalescent plasma will be effective in treating people with the most severe symptoms of the virus. Additionally, it is hoped that it can keep those people who are not as sick from COVID-19 from getting any sicker.
Convalescent plasma is also known as passive antibody therapy, meaning that while it can immediately provide a person with antibodies to fight a virus, those antibodies only last a short period of time i
#Plasmatherapy #covid19 #plasmatreatment #plasmatreatmenturdu
What is convalescent plasma therapy?
A newly approved treatment with some history of success could offer hope for the sickest of the country’s COVID-19 patients.
The U.S. Food and Drug Administration has approved the use of convalescent plasma therapy as an experimental treatment in clinical trials and for critically ill COVID-19 patients without other treatment options.
The therapy, which takes antibodies from the blood of a person who has recovered from a virus and transfuses those antibodies into a person sick with that virus, has long been used as a way to help kickstart a person’s immune system.
Since the March 24 FDA approval, 11 critically ill COVID-19 patients in New York City and Houston received experimental treatment using convalescent care. The results of those cases have not been reported yet.
The therapy has also been used in other parts of the world.
A study of 10 patients in China who have undergone convalescent therapy showed a shortening of the duration of symptoms, improve oxygen levels and a drop in the “virus load” or the amount of virus in a person’s body.
With a vaccine likely months to a year away, scientists hope that convalescent plasma therapy can help those sickest with the virus now.
How does the therapy work, who can it help and what are the results so far? Here’s what we know about convalescent plasma therapy.
What is convalescent plasma?
Convalescent plasma therapy involves transfusing certain components from the blood of people who have had the COVID-19 virus and recovered into people who are very sick with the virus or people who are at high risk of getting the virus.
How does it work
As people fight the COVID-19 virus, they produce antibodies that attack the virus. Those antibodies, proteins that are secreted by immune cells known as B lymphocytes, are found in plasma, or the liquid part of blood that helps the blood to clot when needed and supports immunity.
Once a person has had the virus and recovered, that person has developed antibodies that will stay in their blood waiting to fight the same virus should it return. Those antibodies, when injected into another person with the disease, recognize the virus as something to attack.
In the case of the coronavirus, scientists say antibodies attack the spikes on the outside of the virus, blocking the virus from penetrating human cells.
Who would it help?
Researchers hope that convalescent plasma will be effective in treating people with the most severe symptoms of the virus. Additionally, it is hoped that it can keep those people who are not as sick from COVID-19 from getting any sicker.
Convalescent plasma is also known as passive antibody therapy, meaning that while it can immediately provide a person with antibodies to fight a virus, those antibodies only last a short period of time i
Report form
RELATED VIDEOS
